The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prediction of response to neoadjuvant chemotherapy of patients with muscle invasive bladder cancer by molecular subtyping and antibody drug conjugate target gene quantitation: Preview of Bladder BRIDGister.
 
Ralph M. Wirtz
Employment - STRATIFYER Molecular Pathology
Leadership - STRATIFYER Molecular Pathology
Stock and Other Ownership Interests - STRATIFYER Molecular Pathology
Consulting or Advisory Role - Intellexon
Research Funding - Intellexon; Janssen Research & Development
Patents, Royalties, Other Intellectual Property - STRATIFYER Molecular Pathology
Travel, Accommodations, Expenses - Janssen Research & Development
 
Paula Carolin Voss
No Relationships to Disclose
 
Frank Friedersdorff
No Relationships to Disclose
 
Dimitri Barski
No Relationships to Disclose
 
Thomas Otto
No Relationships to Disclose
 
Michael Waldner
No Relationships to Disclose
 
Elke Veltrup
Employment - STRATIFYER Molecular Pathology
Research Funding - Janssen Research & Development
 
Friederike Linden
Employment - STRATIFYER Molecular Pathology
Research Funding - Janssen Research & Development
 
Meike Schwandt
Employment - STRATIFYER Molecular Pathology
Research Funding - Janssen Research & Development
 
Roland Hake
No Relationships to Disclose
 
Sebastian Eidt
Stock and Other Ownership Interests - STRATIFYER Molecular Pathology
 
Jenny Roggisch
No Relationships to Disclose
 
Constantin Rieger
No Relationships to Disclose
 
Lucas Kastner
No Relationships to Disclose
 
Axel Heidenreich
Honoraria - Amgen; Astellas Pharma; Bayer; Ferring; Ipsen; Janssen-Cilag; Sanofi; Takeda
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; BMS Global; Clovis Oncology; Janssen-Cilag; MSD Oncology
Speakers' Bureau - Amgen; Astellas Pharma; Bayer; Ipsen; Johnson & Johnson; Pfizer; Sanofi; Takeda
Research Funding - Astellas Pharma; Bayer; BMS Oncology; Sanofi
 
Stefan Koch
No Relationships to Disclose
 
Thorsten H Ecke
Research Funding - STRATIFYER Molecular Pathology
Patents, Royalties, Other Intellectual Property - STRATIFYER Molecular Pathology